CUL4A and small cell lung carcinoma: Based on these results, we conclude that CDK4/6 inhibitors may regulate CDK6 degradation via the AMBRA1‐CUL4A complex and negatively impact lysosomal function via TFEB and TFE3, followed by impaired autophagy and SCLC cell death (Figure 7F).